A landmark five-year study has revealed that the biologic therapy guselkumab sustains clinical remission in 97.7 percent of patients with moderate to severe Crohn's disease without any new safety risks.
Most Recent Articles
International Multi-Site Brain Network Harmonization via the ENIGMA Bipolar Working Group
The largest diffusion MRI network study to date has mapped the brain's white matter communication pathways, revealing how bipolar disorder reorganizes neural wiring based on illness duration and medication.
Directional Heart Muscle Cell Growth Governed by Microtubule-Mediated RNA Export
Researchers have discovered that the stability of a heart cell's internal skeleton and specific signaling pathways dictate whether the heart muscle thickens or stretches under stress.
Clinical Practice Guideline for the Staging and Management of Cardiovascular-Kidney-Metabolic Syndrome
Leading medical organizations have released the first official clinical guideline to diagnose and manage cardiovascular-kidney-metabolic syndrome, a major health threat affecting nearly 90 percent of adults.
Metabolic Flexibility vs Unrestrained Oxidation: Therapeutic Windows for Early Heart Failure
UT Southwestern researchers have discovered that forcing heart cells to over-burn fat paradoxically destroys their own mitochondrial architecture, triggering cardiolipin loss and severe dilated cardiomyopathy.